Published in Stroke on February 02, 2012
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE) (BASE) | NCT02014896
microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS One (2014) 0.96
RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol (2013) 0.91
All's well that transcribes well: non-coding RNAs and post-stroke brain damage. Neurochem Int (2013) 0.88
Whole genome expression of cellular response to stroke. Stroke (2013) 0.82
Gene expression profiling in stroke: relevance of blood-brain interaction. Curr Opin Pharmacol (2015) 0.77
A new role for downstream Toll-like receptor signaling in mediating immediate early gene expression during focal cerebral ischemia. J Cereb Blood Flow Metab (2013) 0.77
Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack. Brain (2016) 0.75
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
B cells regulate autoimmunity by provision of IL-10. Nat Immunol (2002) 7.30
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet (2007) 7.27
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet (2007) 6.29
The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol (2007) 4.12
B lymphocytes: how they develop and function. Blood (2008) 4.07
A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood (2009) 3.63
Incidence and prognosis of transient neurological attacks. JAMA (2007) 3.21
Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol (2008) 2.84
Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol (2010) 2.44
TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol (2009) 2.44
B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol (2007) 2.43
Filtering for increased power for microarray data analysis. BMC Bioinformatics (2009) 2.30
Toll-like receptors in ischemia-reperfusion injury. Shock (2009) 1.92
Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol (2011) 1.77
Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci (2011) 1.63
Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke (2009) 1.61
Gene expression profiling of blood for the prediction of ischemic stroke. Stroke (2010) 1.61
Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol (2010) 1.50
Leukocyte recruitment and ischemic brain injury. Neuromolecular Med (2009) 1.47
Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res (2009) 1.38
Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol (2008) 1.30
Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke (2008) 1.28
Very brief focal ischemia simulating transient ischemic attacks (TIAs) can injure brain and induce Hsp70 protein. Brain Res (2008) 1.25
Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J Cereb Blood Flow Metab (2011) 1.25
Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology (2010) 1.23
Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke (2010) 1.21
Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke (1984) 1.19
Diagnostic usefulness of the ABCD2 score to distinguish transient ischemic attack and minor ischemic stroke from noncerebrovascular events: the North Dublin TIA Study. Stroke (2009) 1.18
Diagnosis of transient ischemic attack by the nonneurologist. A validation study. Stroke (1996) 1.16
Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. Stroke (2010) 1.15
Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke. J Cereb Blood Flow Metab (2011) 1.10
Brief focal cerebral ischemia that simulates transient ischemic attacks in humans regulates gene expression in rat peripheral blood. J Cereb Blood Flow Metab (2009) 1.02
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol (2010) 0.99
Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin Immunol (2011) 0.93
Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response. Drugs Today (Barc) (2003) 0.78
Transient neurological attack: a useful concept? JAMA (2007) 0.77
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol (2011) 4.10
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Risk of stroke in children: ethnic and gender disparities. Neurology (2003) 3.47
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol (2006) 3.18
Global variation in the relative burden of stroke and ischemic heart disease. Circulation (2011) 3.02
Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab (2009) 2.85
Financial anatomy of neuroscience research. Ann Neurol (2006) 2.71
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke (2004) 2.42
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab (2006) 2.20
Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol (2006) 2.17
Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab (2003) 2.16
In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. J Neurosci (2002) 2.12
Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med (2008) 2.07
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05
Getting youth in the game: can we accelerate training for clinician-scientists? Ann Neurol (2010) 2.04
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Posterior reversible encephalopathy syndrome in the context of phentermine use resulting in intracranial hemorrhage. Neurologist (2011) 1.99
Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain. J Neurosci (2004) 1.94
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke. Ann Neurol (2012) 1.94
Moyamoya disease in Washington State and California. Neurology (2005) 1.88
Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke (2008) 1.88
Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86
Thirty-year projections for deaths from ischemic stroke in the United States. Stroke (2003) 1.86
Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke (2011) 1.84
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun (2008) 1.79
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke (2012) 1.77
EST sequencing and phylogenetic analysis of the model grass Brachypodium distachyon. Theor Appl Genet (2006) 1.77
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics (2009) 1.73
Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke (2008) 1.72
A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke (2011) 1.72
Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke (2010) 1.71
Translational research for a new administration: what sort of change to believe in? Ann Neurol (2008) 1.71
Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ (2009) 1.70
Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department. Stroke (2012) 1.65
Recruiting subjects for acute stroke trials: a meta-analysis. Stroke (2005) 1.65
Gene expression profiling of blood for the prediction of ischemic stroke. Stroke (2010) 1.61
Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation (2012) 1.58
Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke (2009) 1.56
Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke (2009) 1.56
High critical care usage due to pediatric stroke: results of a population-based study. Neurology (2012) 1.56
Neurological disease on the global agenda. Ann Neurol (2008) 1.56
Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One (2009) 1.55
Gene expression changes in children with autism. Genomics (2007) 1.55
Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat. Stroke (2004) 1.54
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53
Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J Neurochem (2002) 1.52
Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem (2002) 1.52
Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke (2007) 1.51
Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J Cereb Blood Flow Metab (2008) 1.50
Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol (2010) 1.50